• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Autologous stem cell transplantation in an older adult population.

作者信息

Fedorov Kateryna, Jain Tanim, Pradhan Kith, Mustafa Jennat, Lombardo Amanda, Khatun Fariha, Joseph Felisha, Gillick Kailyn, Naik Anjali, Elkind Richard, Fehn Karen, De Castro Alyssa, Browne Roy, Abreu Michelly, Binakaj Donika, Paroder Monika, Palesi Carlo, Gritsman Kira, Sica R Alejandro, Kornblum Noah, Shastri Aditi, Mantzaris Ioannis, Shah Nishi, Verma Amit, Braunschweig Ira, Goldfinger Mendel

机构信息

Department of Oncology.

Department of Medicine.

出版信息

Haematologica. 2022 Sep 1;107(9):2261-2265. doi: 10.3324/haematol.2022.281020.

DOI:10.3324/haematol.2022.281020
PMID:35615933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9425306/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a1/9425306/fc1fb82ed8bf/1072261.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a1/9425306/fc1fb82ed8bf/1072261.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a1/9425306/fc1fb82ed8bf/1072261.fig1.jpg

相似文献

1
Autologous stem cell transplantation in an older adult population.老年人群中的自体干细胞移植。
Haematologica. 2022 Sep 1;107(9):2261-2265. doi: 10.3324/haematol.2022.281020.
2
Real-word data on autologous stem cell transplantation in older patients with multiple myeloma.老年多发性骨髓瘤患者自体干细胞移植的真实世界数据。
Ann Hematol. 2020 Feb;99(2):375-376. doi: 10.1007/s00277-019-03878-6. Epub 2019 Dec 10.
3
Journey of a Patient With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.多发性骨髓瘤患者自体干细胞移植之旅。
Clin J Oncol Nurs. 2022 Jun 1;26(3):252-256. doi: 10.1188/22.CJON.252-256.
4
Use of autologous stem cells cryopreserved for over 15 years in stem cell transplantation for multiple myeloma.
Bone Marrow Transplant. 2021 Apr;56(4):978-979. doi: 10.1038/s41409-020-01131-7. Epub 2020 Nov 11.
5
Autologous Stem Cell Transplantation for Multiple Myeloma: Underutilized but Highly Effective.多发性骨髓瘤的自体干细胞移植：未得到充分利用但疗效显著。
J Natl Cancer Inst. 2019 Jan 1;111(1):7-8. doi: 10.1093/jnci/djy102.
6
Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78.75至78岁多发性骨髓瘤患者的自体干细胞移植
Bone Marrow Transplant. 2021 Aug;56(8):2016-2018. doi: 10.1038/s41409-021-01295-w. Epub 2021 Apr 19.
7
Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma.美法仑剂量强度在多发性骨髓瘤自体干细胞移植中的应用
Haematologica. 2021 Dec 1;106(12):3211-3214. doi: 10.3324/haematol.2021.279179.
8
Autologous stem cell transplantation in elderly multiple myeloma patients aged ≥65 years: a two-centre Australian experience.老年多发性骨髓瘤患者（年龄≥65 岁）自体干细胞移植：来自澳大利亚两个中心的经验。
Intern Med J. 2021 Feb;51(2):280-283. doi: 10.1111/imj.15182.
9
High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma.多发性骨髓瘤患者接受大剂量美法仑一日疗法与两日以上疗法，随后进行自体干细胞移植作为巩固治疗的对比研究
Br J Haematol. 2022 Mar;196(6):e67-e70. doi: 10.1111/bjh.17980. Epub 2021 Dec 27.
10
Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions.多发性骨髓瘤自体造血干细胞移植：常见问题解答
Clin J Oncol Nurs. 2013 Dec;17 Suppl:43-7. doi: 10.1188/13.CJON.43-47.

引用本文的文献

1
The Effect of Age on High-Dose Therapy with Autologous Stem Cell Support in Multiple Myeloma: A Single-Center Experience.年龄对多发性骨髓瘤自体干细胞支持下大剂量治疗的影响：单中心经验
J Clin Med. 2024 Jul 16;13(14):4142. doi: 10.3390/jcm13144142.

本文引用的文献

1
Diffuse Large B-Cell Lymphoma.弥漫性大 B 细胞淋巴瘤。
N Engl J Med. 2021 Mar 4;384(9):842-858. doi: 10.1056/NEJMra2027612.
2
Socioeconomic Factors and Survival of Multiple Myeloma Patients.社会经济因素与多发性骨髓瘤患者的生存情况
Cancers (Basel). 2021 Feb 3;13(4):590. doi: 10.3390/cancers13040590.
3
Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents.自体干细胞移植治疗新型药物治疗的≥75 岁多发性骨髓瘤患者。
Bone Marrow Transplant. 2021 May;56(5):1144-1150. doi: 10.1038/s41409-020-01159-9. Epub 2020 Dec 4.
4
Daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma: final results from the phase 2 GEN501 and SIRIUS trials.达雷妥尤单抗单药治疗经大量预处理的复发或难治性多发性骨髓瘤患者：2期GEN501和SIRIUS试验的最终结果
Lancet Haematol. 2020 Jun;7(6):e447-e455. doi: 10.1016/S2352-3026(20)30081-8.
5
Multiple myeloma: Role of autologous transplantation.多发性骨髓瘤：自体移植的作用。
Cancer Treat Rev. 2020 Jan;82:101929. doi: 10.1016/j.ctrv.2019.101929. Epub 2019 Nov 11.
6
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study.依沙佐米联合泊马度胺和低剂量地塞米松与泊马度胺和低剂量地塞米松治疗复发/难治性多发性骨髓瘤患者（ICARIA-MM）：一项随机、多中心、开放性、3 期研究。
Lancet. 2019 Dec 7;394(10214):2096-2107. doi: 10.1016/S0140-6736(19)32556-5. Epub 2019 Nov 14.
7
Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis.多发性骨髓瘤患者治疗模式和结局的种族差异：SEER-医疗保险分析。
Blood Adv. 2019 Oct 22;3(20):2986-2994. doi: 10.1182/bloodadvances.2019000308.
8
Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma.口服塞利尼索联合地塞米松治疗三药难治性多发性骨髓瘤。
N Engl J Med. 2019 Aug 22;381(8):727-738. doi: 10.1056/NEJMoa1903455.
9
Analysis of Racial/Ethnic Representation in Select Basic and Applied Cancer Research Studies.分析部分基础和应用癌症研究中代表性不足的种族/民族问题。
Sci Rep. 2018 Sep 18;8(1):13978. doi: 10.1038/s41598-018-32264-x.
10
Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.自体干细胞移植在 70 多岁老年淋巴瘤患者中的应用：结果与分析。
Oncologist. 2018 May;23(5):624-630. doi: 10.1634/theoncologist.2017-0499. Epub 2017 Dec 28.